PortViewPortView
MetLife, 5.875% Senior Notes due 11/21/2033 logo

MetLife, 5.875% Senior Notes due 11/21/2033 (MLG) Stock Analysis

NYSEFinancial ServicesInsurance - Life

$0.15-6.90%
52-week range$0.15
$0.14$0.17

What MetLife, 5.875% Senior Notes due 11/21/2033 does

MetLife, 5.875% Senior Notes due 11/21/2033 (NYSE: MLG) is a Insurance - Life company in the Financial Services sector.

Key metrics

Market cap
$0
P/E (TTM)
0.00
Beta
-71.22
Dividend yield
2.41%
Revenue / share
$120.62
50-day avg
$0.15
200-day avg
$0.15
52-week high
$0.17
52-week low
$0.14

ETFs linked to MLG

Broad-market and Financial Services sector ETFs an investor holding MetLife, 5.875% Senior Notes due 11/21/2033 is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MLG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MLG in PortView →

Frequently asked questions

What is the ticker symbol for MetLife, 5.875% Senior Notes due 11/21/2033?
MetLife, 5.875% Senior Notes due 11/21/2033 trades under the ticker MLG on NYSE.
Which exchange is MLG listed on?
MLG is listed on NYSE.
What sector does MetLife, 5.875% Senior Notes due 11/21/2033 operate in?
MetLife, 5.875% Senior Notes due 11/21/2033 is classified in the Financial Services sector (Insurance - Life industry).
How can PortView help analyze MLG in a portfolio?
PortView shows MLG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.